Takeda Pharmaceutical (TAK) EBT Margin (2017 - 2026)
Takeda Pharmaceutical's (TAK) quarterly EBT Margin came in at 41.57% in Q1 2026, down 5404.0% year-on-year from 0.78% in Q1 2025, and little changed quarter-over-quarter from 41.57% in Q4 2025.
Takeda Pharmaceutical (TAK) EBT Margin (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's EBT Margin history runs 10 years deep, the most recent figure standing at 41.57% for Q1 2026.
- On a quarterly basis, EBT Margin fell 5404.0% year-over-year to 41.57% in Q1 2026; TTM through Mar 2026 was 6.3%, a 1290.0% decrease from a year earlier, with the FY2026 full-year figure at 3.16%, down 698.0% from the prior year.
- EBT Margin was little changed at 41.57% in Q1 2026 per TAK's latest filing, from 41.57% in the prior quarter.
- Across five years, EBT Margin topped out at 22.93% in Q1 2022 and bottomed at 41.57% in Q1 2026.
- The 5-year median for EBT Margin is 10.15% (2025), against an average of 3.89%.
- Across the five-year window, EBT Margin jumped 594 bps in 2022 and plunged 5404 bps in 2026, its largest moves.
- Year by year, EBT Margin stood at 9.77% in 2022, then sank by 53 bps to 4.56% in 2023, then plunged by 323 bps to 10.19% in 2024, then sank by 308 bps to 41.57% in 2025, then slipped by 0 bps to 41.57% in 2026.
- Per Business Quant, the three latest TAK EBT Margin figures stand at 41.57% (Q1 2026), 41.57% (Q4 2025), and 8.86% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 40.73% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 6.35% |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -3.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.57% |
| Dec 31, 2025 | -41.57% |
| Sep 30, 2025 | 8.86% |
| Jun 30, 2025 | 10.15% |
| Mar 31, 2025 | 12.47% |
| Dec 31, 2024 | -10.19% |
| Sep 30, 2024 | 8.00% |
| Jun 30, 2024 | 11.31% |
| Mar 31, 2024 | 11.31% |
| Dec 31, 2023 | 4.56% |
| Sep 30, 2023 | 10.18% |
| Jun 30, 2023 | 12.76% |
| Mar 31, 2023 | 14.69% |
| Dec 31, 2022 | 9.77% |
| Sep 30, 2022 | 6.44% |
| Jun 30, 2022 | 15.99% |
| Mar 31, 2022 | 22.93% |
| Dec 31, 2021 | 8.01% |
| Sep 30, 2021 | 7.27% |
| Jun 30, 2021 | 23.48% |